Previous 10 | Next 10 |
Inogen, Inc. (INGN) Q4 2020 Earnings Conference Call February 24, 2021 4:30 PM ET Company Participants Matt Pigeon – Investor Relations Nabil Shabshab – President and Chief Executive Officer Ali Bauerlein – Chief Financial Officer and Co-Founder Conference Call Participan...
Image source: The Motley Fool. Inogen Inc (NASDAQ: INGN) Q4 2020 Earnings Call Feb 24, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Inogen Inc (INGN) Q4 2020 Earnings Call Transcript
Inogen (INGN): Q4 GAAP EPS of -$0.23 beats by $0.03.Revenue of $73.98M (-6.2% Y/Y) beats by $4.91M.Press Release For further details see: Inogen EPS beats by $0.03, beats on revenue
– Q4 2020 Total Revenue of $74.0 million – – Q4 2020 Rental Revenue of $9.4 million, up 71.7% from the same period in 2019 – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory product...
[[ACA]], [[ACAD]], [[ADPT]], [[AGI]], [[AMED]], [[ANSS]], [[APA]], [[AWK]], [[BILI]], [[BKNG]], [[CCRN]], [[CDNA]], [[CHDN]], [[CNXN]], [[CW]], [[DDD]], [[DOOR]], [[DRH]], [[ECPG]], [[EPR]], [[ESI]], [[ESTC]], [[FATE]], [[FNF]], [[FTI]], [[GBT]], [[GEF]], [[GH]], [[HCC]], [[ICLR]], [[INGN]], ...
Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Kristen Miranda has been appointed to its Board of Directors, effective March 1, 2021. In addition, Ms. Miranda was appointed to the B...
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 10 th Annual SVB Leerink Healthcare Conference. Inogen...
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter and year end 2020 financial results after market close on Wednesday, February 24 th , 2021. The...
Inogen (INGN) has appointed Nabil Shabshab as President, Chief Executive Officer and also o the Board of Directors, effective February 8, 2021.Mr. Shabshab will succeed Scott Wilkinson, who is retiring on February 8, 2021. Most recently, Mr. Shabshab, has served as Worldwide President of Diab...
- Nabil Shabshab to Succeed Scott Wilkinson as President and CEO and Join the Board of Directors Effective February 8, 2021 - Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced tod...
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...